Shandong Luoxin Phrm Stock Fundamentals
SHANDONG LUOXIN PHRM fundamentals help investors to digest information that contributes to SHANDONG LUOXIN's financial success or failures. It also enables traders to predict the movement of SHANDONG Pink Sheet. The fundamental analysis module provides a way to measure SHANDONG LUOXIN's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SHANDONG LUOXIN pink sheet.
SHANDONG |
SHANDONG Return On Asset Analysis
SHANDONG LUOXIN's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current SHANDONG LUOXIN Return On Asset | 8.17 |
Most of SHANDONG LUOXIN's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SHANDONG LUOXIN PHRM is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, SHANDONG LUOXIN PHRM has a Return On Asset of 8.17. This is much higher than that of the sector and significantly higher than that of the Return On Asset industry. The return on asset for all United States stocks is notably lower than that of the firm.
SHANDONG LUOXIN PHRM Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SHANDONG LUOXIN's current stock value. Our valuation model uses many indicators to compare SHANDONG LUOXIN value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SHANDONG LUOXIN competition to find correlations between indicators driving SHANDONG LUOXIN's intrinsic value. More Info.SHANDONG LUOXIN PHRM is rated fourth in earnings per share category among related companies. It is rated second in current ratio category among related companies fabricating about 32.13 of Current Ratio per Earnings Per Share. . Comparative valuation analysis is a catch-all model that can be used if you cannot value SHANDONG LUOXIN by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for SHANDONG LUOXIN's Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SHANDONG LUOXIN's earnings, one of the primary drivers of an investment's value.SHANDONG Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SHANDONG LUOXIN's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of SHANDONG LUOXIN could also be used in its relative valuation, which is a method of valuing SHANDONG LUOXIN by comparing valuation metrics of similar companies.SHANDONG LUOXIN is currently under evaluation in net income category among related companies.
SHANDONG Fundamentals
Return On Equity | 12.54 | |||
Return On Asset | 8.17 | |||
Profit Margin | 7.86 % | |||
Operating Margin | 7.38 % | |||
Current Valuation | 601.93 M | |||
Shares Outstanding | 609.6 M | |||
Price To Earning | 3.10 X | |||
Price To Book | 2.27 X | |||
Price To Sales | 1.99 X | |||
Revenue | 646.45 M | |||
Gross Profit | 3.12 B | |||
EBITDA | 59.31 M | |||
Net Income | 50.79 M | |||
Cash And Equivalents | 247.39 M | |||
Cash Per Share | 0.41 X | |||
Current Ratio | 2.57 X | |||
Book Value Per Share | 0.68 X | |||
Cash Flow From Operations | 91.41 M | |||
Earnings Per Share | 0.08 X | |||
Number Of Employees | 13 | |||
Market Capitalization | 1.29 B |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in SHANDONG Pink Sheet
If you are still planning to invest in SHANDONG LUOXIN PHRM check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SHANDONG LUOXIN's history and understand the potential risks before investing.
Transaction History View history of all your transactions and understand their impact on performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Equity Valuation Check real value of public entities based on technical and fundamental data |